<?xml version="1.0" encoding="utf-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
<mods version="3.7">
      <titleInfo>
         <title>Humanized monoclonal antibody IgG1k, NISTmAb RM 8671 summary of 5
                year stability verification (5YSV)</title>
      </titleInfo>
      <name type="personal" usage="primary">
         <namePart>Yandrofski, Katharina</namePart>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0002-0570-8011">
         <namePart>Yandrofski, Katharina.</namePart>
         <nameIdentifier>(orcid)0000-0002-0570-8011</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0001-5353-3343">
         <namePart>Schiel, John E.</namePart>
         <nameIdentifier>(orcid)0000-0001-5353-3343</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0002-6790-830X">
         <namePart>Mouchahoir, Trina.</namePart>
         <nameIdentifier>(orcid)0000-0002-6790-830X</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0003-4687-6123">
         <namePart>Telikepalli, Srivalli.</namePart>
         <nameIdentifier>(orcid)0000-0003-4687-6123</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0002-6413-1339">
         <namePart>Ripple, Dean C.</namePart>
         <nameIdentifier>(orcid)0000-0002-6413-1339</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0001-7540-5860">
         <namePart>Phinney, Karen W.</namePart>
         <nameIdentifier>(orcid)0000-0001-7540-5860</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0002-6860-5853">
         <namePart>Marino, John P.</namePart>
         <nameIdentifier>(orcid)0000-0002-6860-5853</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0002-1406-633X">
         <namePart>DeRose, Paul C.</namePart>
         <nameIdentifier>(orcid)0000-0002-1406-633X</nameIdentifier>
      </name>
      <name type="personal" xlink:href="(orcid)0000-0002-8430-6757">
         <namePart>Heckert, N. Alan.</namePart>
         <nameIdentifier>(orcid)0000-0002-8430-6757</nameIdentifier>
      </name>
      <name type="corporate">
         <namePart>National Institute of Standards and Technology (U.S.)</namePart>
         <namePart>Material Measurement Laboratory.</namePart>
      </name>
      <typeOfResource>text</typeOfResource>
      <genre authority="marcgt">encyclopedia</genre>
      <genre authority="rdacontent">text</genre>
      <originInfo>
         <place>
            <placeTerm type="code" authority="marccountry">ot</placeTerm>
         </place>
         <dateIssued encoding="marc">2023</dateIssued>
         <issuance>monographic</issuance>
      </originInfo>
      <originInfo eventType="publisher">
         <place>
            <placeTerm type="text">Gaithersburg, MD :</placeTerm>
         </place>
         <publisher>U.S. Dept. of Commerce, National Institute of Standards and
                Technology ;</publisher>
         <dateIssued>2023-03-01.</dateIssued>
      </originInfo>
      <physicalDescription>
         <form authority="marcform">print</form>
         <form type="carrier" authority="rdacarrier">online resource</form>
         <extent>1 online resource (74 pages) : illustrations (color)</extent>
      </physicalDescription>
      <abstract displayLabel="Abstract">NISTmAb RM 8671 is an IgG1k monoclonal antibody that has been
                extensively characterized and released as the first of its kind biopharmaceutical
                reference material in 2016. This material was intended primarily for use in
                evaluating the performance of methods for determining physicochemical and
                biophysical attributes of monoclonal antibodies. It also provides a representative
                test molecule for development of novel technologies for therapeutic protein
                characterization. The lifecycle management of NISTmAb includes a long-term stability
                verification to evaluate the homogeneity and stability for the first 3 lots
                (14HB-D001, 14HB-D-002, and 14HB-D-003) of this material. Initial certification to
                assign property values and confirm identification used a wide variety of analytical
                methods including UVVis spectrophotometry, size exclusion chromatography, capillary
                electrophoresis, dynamic light scattering, flow imaging, and peptide mapping.
                Reported here is a summary of these analytical methods and results for the 5-year
                stability verification (5YSV) for RM 8671 demonstrating the material is homogeneous
                and stable.</abstract>
      <note type="statement of responsibility">Katharina Yandrofski; John E. Schiel; Trina Mouchahoir; Srivalli
                Telikepalli; Dean C. Ripple; Karen W. Phinney; John P. Marino; Paul C. DeRose; Alan
                N. Heckert.</note>
      <note>March 2023</note>
      <note>Title from PDF title page (viewed April 14, 2023).</note>
      <note type="bibliography">Includes bibliographical references.</note>
      <note type="venue">Approved by the NIST Editorial Review Board on 2023-03-27</note>
      <note type="system details">Mode of access: World Wide Web.</note>
      <note type="system details">Systems requirements: Adobe Acrobat PDF reader.</note>
      <subject authority="lcsh">
         <name type="corporate">
            <namePart>Standard reference materials</namePart>
         </name>
      </subject>
      <subject authority="lcsh">
         <name type="corporate">
            <namePart>Standard Reference Materials Program (National Institute of Standards
                and Technology (U.S.))</namePart>
         </name>
      </subject>
      <subject authority="lcsh">
         <topic>Monoclonal antibodies</topic>
      </subject>
      <subject authority="lcsh">
         <topic>Pharmaceutical biotechnology</topic>
      </subject>
      <subject>
         <topic>NISTmAb</topic>
      </subject>
      <subject>
         <topic>Monoclonal antibody</topic>
      </subject>
      <subject>
         <topic>Biotherapeutic</topic>
      </subject>
      <subject>
         <topic>Biopharmaceutical</topic>
      </subject>
      <subject>
         <topic>System suitability</topic>
      </subject>
      <location>
         <url displayLabel="electronic resource" usage="primary display">https://doi.org/10.6028/NIST.SP.260-237</url>
      </location>
      <relatedItem type="series">
         <titleInfo>
            <title>NIST special publication; NIST special pub; NIST SP</title>
            <partNumber>260-237</partNumber>
         </titleInfo>
      </relatedItem>
      <identifier type="oclc">1405859677</identifier>
      <identifier type="oclc">on1405859677</identifier>
      <recordInfo>
         <descriptionStandard>rda</descriptionStandard>
         <recordContentSource authority="marcorg">NBS</recordContentSource>
         <recordCreationDate encoding="marc">231024</recordCreationDate>
         <recordChangeDate encoding="iso8601">20240401111410.0</recordChangeDate>
         <recordIdentifier>991000614605508106</recordIdentifier>
         <recordOrigin>Converted from MARCXML to MODS version 3.7 using MARC21slim2MODS3-7.xsl
				(Revision 1.140 20200717)</recordOrigin>
         <languageOfCataloging>
            <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
         </languageOfCataloging>
      </recordInfo>
   </mods></modsCollection>
